A comprehensive risk model of disulfidoptosis-related lncRNAs predicts prognosis and therapeutic implications in bladder cancer
The dr-lncRNAs-based risk model presents a promising tool for predicting prognosis and guiding personalized immunotherapy and treatment strategies in BLCA patients.
Authors
- Jinghua Zhong
- Xiaolu Duan (ORCID: https://orcid.org/0000-0001-7885-1487)
- Zhixiong Zhang (ORCID: https://orcid.org/0000-0002-0947-9981)
- Muhammad Sarfaraz Iqbal (ORCID: https://orcid.org/0000-0001-8861-8179)
- Zhiwen Zeng (ORCID: https://orcid.org/0000-0002-9530-6701)
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Shenzhen KangNing Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Biochemistry and Biophysics Reports
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1016/j.bbrep.2025.102060
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00